TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2010

Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study.

Suzanne Shusterman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.